Marcel F Jonkman Selected Research

Epidermolysis Bullosa

1/2022	Natural Occurrence of Autoantibodies against Basement Membrane Proteins in Epidermolysis Bullosa.
3/2019	Allogeneic Haematopoietic Cell Transplantation for Epidermolysis Bullosa: the Dutch Experience.
1/2018	A "late-but-fitter revertant cell" explains the high frequency of revertant mosaicism in epidermolysis bullosa.
10/2016	Association of Epidermolysis Bullosa Simplex With Mottled Pigmentation and EXPH5 Mutations.
2/2015	IgG4 subclass-specific responses to Staphylococcus aureus antigens shed new light on host-pathogen interaction.
2/2014	Pigmentation and melanocyte supply to the epidermis depend on type XVII collagen.
1/2014	Successful therapeutic transplantation of revertant skin in epidermolysis bullosa.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marcel F Jonkman Research Topics

Disease

17	Pemphigus (Pemphigus Vulgaris) 11/2020 - 06/2002
12	Bullous Pemphigoid (Pemphigoid) 12/2019 - 08/2004
12	Epidermolysis Bullosa Acquisita (Acquired Epidermolysis Bullosa) 01/2018 - 12/2002
10	Blister (Bulla) 01/2019 - 12/2002
8	Skin Diseases (Skin Disease) 01/2020 - 12/2002
7	Epidermolysis Bullosa 01/2022 - 01/2014
7	Epidermolysis Bullosa Dystrophica (Dystrophic Epidermolysis Bullosa) 12/2019 - 10/2009
7	Epidermolysis Bullosa Simplex (Epidermolysis Bullosa Herpetiformis Dowling Meara) 06/2015 - 04/2002
5	Autoimmune Diseases (Autoimmune Disease) 01/2018 - 07/2006
4	Pruritus (Itching) 12/2019 - 12/2018
3	Cicatrix (Scar) 01/2013 - 12/2002
3	lethal acantholytic Epidermolysis bullosa 11/2010 - 10/2005
2	Inflammation (Inflammations) 01/2018 - 06/2015
2	Disease Progression 02/2017 - 11/2016
2	Vesiculobullous Skin Diseases (Subcorneal Pustular Dermatosis) 04/2015 - 02/2013
2	Junctional Epidermolysis Bullosa (Epidermolysis Bullosa Letalis) 05/2012 - 07/2007
2	Acantholysis 01/2010 - 01/2010
1	Hypotrichosis simplex 01/2020
1	Arrhythmogenic Right Ventricular Dysplasia (Arrhythmogenic Right Ventricular Cardiomyopathy) 01/2018
1	Neoplasms (Cancer) 01/2018
1	Squamous Cell Carcinoma of Head and Neck 01/2018
1	Cutaneous Lupus Erythematosus 12/2017
1	Wounds and Injuries (Trauma) 10/2016
1	Pathologic Complete Response 02/2016
1	Hidradenitis Suppurativa 11/2015
1	Cardiomyopathies (Cardiomyopathy) 06/2015
1	Muscular Dystrophies (Muscular Dystrophy) 06/2015
1	Asymptomatic Infections 02/2015
1	Septic Shock (Toxic Shock Syndrome) 02/2015
1	Staphylococcal Infections 02/2015
1	Ulcer 01/2014
1	Rheumatoid Arthritis 02/2013

Drug/Important Bio-Agent (IBA)

17	AutoantibodiesIBA 01/2022 - 04/2003
17	Collagen Type VIIIBA 10/2019 - 04/2003
13	Immunoglobulin G (IgG)IBA 01/2019 - 12/2002
9	Proteins (Proteins, Gene)FDA Link 01/2022 - 04/2006
8	AntigensIBA 11/2016 - 12/2002
7	Collagen Type XVIIIBA 02/2016 - 12/2002
6	AntibodiesIBA 01/2018 - 03/2006
5	Desmoglein 1IBA 01/2019 - 07/2010
4	Dexamethasone (Maxidex)FDA LinkGeneric 03/2011 - 06/2002
4	Desmoplakins (Desmoplakin)IBA 11/2010 - 10/2005
3	Nonsense Codon (Nonsense Mutation)IBA 01/2020 - 02/2012
3	SaltsIBA 08/2019 - 12/2002
3	PlectinIBA 01/2018 - 01/2014
3	Immunoglobulin A (IgA)IBA 01/2018 - 12/2002
3	Keratin-5 (Keratin 5)IBA 07/2011 - 04/2003
3	Keratins (Keratin)IBA 01/2010 - 04/2003
2	Rituximab (Mabthera)FDA Link 11/2020 - 01/2018
2	gamma Catenin (Plakoglobin)IBA 01/2019 - 08/2009
2	DesmogleinsIBA 01/2018 - 12/2017
2	Protein Isoforms (Isoforms)IBA 12/2017 - 06/2015
2	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2016 - 01/2007
2	IntegrinsIBA 11/2015 - 07/2011
2	EpitopesIBA 06/2015 - 04/2006
2	CytokinesIBA 04/2015 - 02/2013
2	Interleukin-6 (Interleukin 6)IBA 04/2015 - 02/2013
2	Antigen-Antibody Complex (Immune Complex)IBA 08/2014 - 08/2004
2	Desmoglein 3IBA 08/2014 - 06/2012
2	KalininIBA 03/2013 - 04/2003
1	Cadherins (E-Cadherin)IBA 01/2019
1	EnzymesIBA 01/2019
1	ImmunosorbentsIBA 01/2019
1	APOBEC DeaminasesIBA 01/2018
1	RNA (Ribonucleic Acid)IBA 01/2018
1	Desmosomal CadherinsIBA 01/2018
1	Nuclear Proteins (Protein, Nuclear)IBA 12/2017
1	DesmocollinsIBA 12/2017
1	Etanercept (Enbrel)FDA Link 02/2017
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2017
1	Leukotriene B4IBA 01/2017
1	Chimeric Antigen ReceptorsIBA 01/2017
1	Dimethyl FumarateIBA 01/2017
1	Doxycycline (Periostat)FDA LinkGeneric 01/2017
1	Dapsone FDA Link 01/2017
1	Type 4 Cyclic Nucleotide PhosphodiesterasesIBA 01/2017
1	Dipeptidyl-Peptidase IV InhibitorsIBA 01/2017
1	AutoantigensIBA 11/2016
1	RoflumilastIBA 11/2016
1	Antisense OligonucleotidesIBA 10/2016
1	Prednisone (Sone)FDA LinkGeneric 02/2016
1	Azathioprine (Imuran)FDA LinkGeneric 02/2016
1	Sodium Chloride FDA LinkGeneric 01/2016
1	Interleukin-1 (Interleukin 1)IBA 04/2015
1	SuperantigensIBA 02/2015
1	staphylococcal enterotoxin CIBA 02/2015
1	Virulence Factors (Pathogenicity Factors)IBA 02/2015
1	Complement Inactivating AgentsIBA 02/2015
1	ExfoliatinsIBA 02/2015
1	Reactive Oxygen Species (Oxygen Radicals)IBA 08/2014
1	Matrix Metalloproteinases (MMPs)IBA 03/2013
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 02/2013
1	Gentamicins (Gentamicin)FDA LinkGeneric 01/2013
1	Floxacillin (Flucloxacillin)IBA 01/2013
1	Sirolimus (Rapamycin)FDA Link 11/2012

Therapy/Procedure

10	Therapeutics 03/2020 - 06/2002
1	Home Nursing (Nursing, Home) 12/2019
1	Cell Transplantation 03/2019
1	Polypharmacy 12/2018
1	Transplantation 01/2014